文献速递神经肿瘤

弥漫性内生性桥脑胶质瘤细胞对瘤内调制治疗低强度电场敏感

Diffuse intrinsic pontine glioma cells are vulnerable to low intensity electric fields delivered by intratumoral modulation therapy.
PubMed 文献 · J Neurooncol · 2019-03-09

该概念验证研究采用尸检来源的弥漫性内生性桥脑胶质瘤(DIPG)细胞,在体外瘤内调制治疗(IMT)系统中接受连续低强度中频电场刺激,并以假处理、替莫唑胺化疗和放疗为对照。结果显示IMT显著降低DIPG细胞活力,活/死细胞比由假处理的约6:1变为IMT处理的约1.5:1,IMT联合替莫唑胺-放疗使细胞活力降至对照的约20%。作者认为该结果支持进一步研究IMT作为DIPG潜在治疗手段。

要点

  • DIPG细胞对IMT低强度电场表现出稳定且明显的敏感性。
  • 活/死细胞比由假处理约6:1降至IMT处理约1.5:1。
  • IMT联合替莫唑胺-放疗使DIPG细胞活力降至对照约20%。

核心结论

  • 概念验证研究首次显示DIPG细胞对IMT低强度电场敏感,单用及联合多模式治疗均有明显作用,作者认为值得进一步研究IMT作为DIPG急需的生物医学创新。

研究设计与样本

  • 概念验证性体外研究,采用尸检标本来源的DIPG细胞,在定制体外IMT系统中以连续低强度中频刺激参数处理,并通过计算机电场模拟量化IMT幅度与分布。
  • 处理分组包括假处理、IMT、替莫唑胺(TMZ)化疗和放疗(RT),比较单模式与多模式治疗的细胞活力。

主要发现

  • IMT电场显著降低DIPG细胞活力,与未处理对照水平相比差异显著。
  • 活/死DIPG细胞比由假处理的约6:1变为IMT处理的约1.5:1。
  • IMT的作用与替莫唑胺-放疗双模式治疗相似,IMT加入该联合方案后使DIPG细胞活力降至对照值的约20%。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Diffuse intrinsic pontine glioma (DIPG) is a high fatality pediatric brain cancer without effective treatment. The field of electrotherapeutics offers new potential for other forms of glioma but the efficacy of this strategy has not been reported for DIPG. This pilot study evaluated the susceptibility of patient-derived DIPG cells to low intensity electric fields delivered using a developing technology called intratumoral modulation therapy (IMT). METHODS: DIPG cells from autopsy specimens were treated with a custom-designed, in vitro IMT system. Computer-generated electric field simulation was performed to quantify IMT amplitude and distribution using continuous, low intensity, intermediate frequency stimulation parameters. Treatment groups included sham, IMT, temozolomide (TMZ) chemotherapy and radiation therapy (RT). The impact of single and multi-modality therapy was compared using spectrophotometric and flow cytometry viability analyses. RESULTS: DIPG cells exhibited robust, consistent susceptibility to IMT fields that significantly reduced cell viability compared to untreated control levels. The ratio of viable:non-viable DIPG cells transformed from ~ 6:1 in sham-treated to ~ 1.5:1 in IMT-treated conditions. The impact of IMT was similar to that of dual modality TMZ-RT therapy and the addition of IMT to this treatment combination dramatically reduced DIPG cell viability to ~ 20% of control values. CONCLUSIONS: This proof-of-concept study provides a novel demonstration of marked DIPG cell susceptibility to low intensity electric fields delivered using IMT. The potent impact as a monotherapy and when integrated into multi-modality treatment platforms justifies further investigations into the potential of IMT as a critically needed biomedical innovation for DIPG.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Deweyert A, Iredale E, Xu H, et al. Diffuse intrinsic pontine glioma cells are vulnerable to low intensity electric fields delivered by intratumoral modulation therapy. J Neurooncol. 2019. PMID: 30852713. doi:10.1007/s11060-019-03145-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。